

A patented DNA-scaffold platform enables programmable particle-surface adhesion, offering high loading capacity and modular control, applicable in biomedical delivery and industrial coatings.

Advanced PLGA nanoparticles with CD40 and TLR9 agonists enhance immune activation in cancer treatments by repolarizing macrophages and priming dendritic cells, aiming to improve tumor microenvironment modulation and syst...